CAN:s bibliotek

*000      am
*00114092
*008070120|2001|||||||||||e||||||||||0|eng|d
*020  $a92-871-4807-4$x92-871-4807-4
*24510$aDevelopment and improvement of substitution programmes :$bproceedings, Strasbourg, France, 8-9 October 2001
*260  $aStrasbourg :$bCouncil of Europe Publ,$c2001$y2001
*300  $a236 s., ill.
*440 0$aDrugs and addiction
*520  $aSubstitution treatment for opioid dependence: a review of the evidence and the impact. Substitution treatment as a part of a risk reduction strategy: medicalisation versus social policy. Difficulties encountered in post-Soviet countries in accepting the principle of substitution treatment. Difficulties encountered in Central and Eastern European countries in accepting methadone substitution. Differential indications for the use of the various substitution products and their therapeutic dosage. Importance of psycho-social support in the use of substitution treatments. Mortality from overdose. Development and implementation of drug policy in Switzerland, a community approach, the example Geneva. Integration as a basic principle. The future: documentation and evaluation (From the table of contents)
*650 4$aSubstance-related disorders
*650 4$aNarcotics
*650 4$aOpioid-related disorders
*650 4$aRehabilitation
*650 4$aEvaluation studies
*650 4$aMethadone
*650 4$aEurope, Eastern
*650 4$aRussia
*650 4$aBaltic States
*650 4$aSwitzerland
*650 4$aHarm reduction
*653  $aNarkotikamissbruk
*653  $aOpiatmissbruk
*653  $aBuprenorfin
*653  $aMetadon
*653  $aNaltrexon
*653  $aUtvärdering
*653  $aMetadon
*653  $aBehandling
*653  $aÖsteuropa
*653  $aRyssland
*653  $aBaltiska länderna
*653  $aSchweiz
*653  $aSkadereduktion
*7101 $aCo-operation Group to Combat Drug Abuse and Illicit trafficking in Drugs
*852  $h5d115
^